fusidic acid has been researched along with metronidazole in 21 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (metronidazole) | Trials (metronidazole) | Recent Studies (post-2010) (metronidazole) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 13,983 | 2,489 | 3,725 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (33.33) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Bal, M; Kaan, JA; Kester, AD; MacLaren, DM; Namavar, F; Vel, WA; Verweij-van Vught, AM | 1 |
| Farthing, MJ; Inge, PM | 2 |
| Bartlett, JG | 1 |
| Symonds, J | 1 |
| Chaouat, A; Grunenberger, S; Ifoundza, TP; Kessler, R; Weitzenblum, E | 1 |
| Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
| Odenholt, I; Wullt, M | 1 |
| Akerlund, T; Aspevall, O; Burman, LG; Lundberg, A; Svenungsson, B | 1 |
| Akerlund, T; Bäck, E; Burman, LG; Norén, T; Odenholt, I; Wullt, M | 1 |
| Odenholt, I; Walder, M; Wullt, M | 1 |
| Nelson, R | 1 |
| Bektaş, M; Cetinkaya, H; Ozden, A; Soykan, I; Toruner, M | 1 |
| Johnson, S; Venugopal, AA | 1 |
| Fan, W; Song, L; Zhang, Q | 1 |
2 review(s) available for fusidic acid and metronidazole
| Article | Year |
|---|---|
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Teicoplanin; Treatment Outcome; Vancomycin | 2007 |
Current state of Clostridium difficile treatment options.
Topics: Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fusidic Acid; Humans; Metronidazole; Nitro Compounds; Secondary Prevention; Severity of Illness Index; Teicoplanin; Thiazoles; Treatment Outcome; Vancomycin | 2012 |
4 trial(s) available for fusidic acid and metronidazole
| Article | Year |
|---|---|
Treatment of Clostridium difficile colitis.
Topics: Animals; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Random Allocation; Vancomycin | 1985 |
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1996 |
A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Double-Blind Method; Female; Follow-Up Studies; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Sweden; Treatment Outcome | 2004 |
Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Double-Blind Method; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prospective Studies; Treatment Outcome | 2006 |
15 other study(ies) available for fusidic acid and metronidazole
| Article | Year |
|---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Chemotherapy of brain abscess.
Topics: Ampicillin; Bacteroides fragilis; Bacteroides Infections; Brain Abscess; Chloramphenicol; Fusidic Acid; Gentamicins; Humans; Metronidazole; Penicillins; Prevotella melaninogenica; Staphylococcal Infections; Streptococcal Infections | 1978 |
Susceptibility of Clostridium difficile to LY146032.
Topics: Anti-Bacterial Agents; Bacitracin; Clostridium; Daptomycin; Fusidic Acid; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Clindamycin; Complement C3; Complement Fixation Tests; Complement System Proteins; Escherichia coli; Fusidic Acid; Humans; Luminescent Measurements; Metronidazole; Neutrophils; Opsonin Proteins; Phagocytosis | 1986 |
A radiometric assay for antigiardial drugs.
Topics: Antiprotozoal Agents; Fusidic Acid; Giardia; Metronidazole; Quinacrine; Thymidine; Tritium | 1987 |
Antigiardial activity of the bile salt-like antibiotic sodium fusidate.
Topics: Animals; Cholic Acid; Cholic Acids; Fusidic Acid; Giardia; Metronidazole; Microbial Sensitivity Tests; Taurocholic Acid | 1986 |
Oral or parenteral antibiotic treatment in serious infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Infusions, Parenteral; Metronidazole; Penicillins | 1984 |
[Diffuse nodular dissemination of thoracic actinomycosis].
Topics: Actinomycosis; Adult; Drug Therapy, Combination; Fusidic Acid; Humans; Male; Metronidazole; Radiography; Rifampin; Tetracycline Resistance; Tetracyclines; Thoracic Diseases; Time Factors | 1994 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Drug Resistance, Bacterial; Fusidic Acid; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Serotyping; Sweden; Vancomycin | 2006 |
Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Dose-Response Relationship, Drug; Fusidic Acid; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2007 |
Fucidic acid use in metronidazole nonresponders with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clostridium Infections; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 2007 |
An unusual case of folliculitis spinulosa decalvans.
Topics: Adult; Alopecia; Anti-Infective Agents; Clarithromycin; Dermatologic Agents; Diagnosis, Differential; Folliculitis; Fusidic Acid; Humans; Keratosis; Male; Metronidazole; Scalp; Scalp Dermatoses; Skin; Treatment Outcome; Tretinoin | 2016 |